Source: Frontiers in Pharmacology. Unidade: FCF
Subjects: COVID-19, FARMACOVIGILÂNCIA, MEDICAMENTO, PACIENTES INTERNADOS, UNIDADES DE TERAPIA INTENSIVA
ABNT
SOUZA, Rafael Nogueira de et al. Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units. Frontiers in Pharmacology, v. 16, p. 1-12 art. 1514942, 2025Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2025.1514942. Acesso em: 12 fev. 2026.APA
Souza, R. N. de, Visacri, M. B., Trotta, F. B. A., Ventura, D. de S., Perroud Junior, M. W., & Moriel, P. (2025). Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units. Frontiers in Pharmacology, 16, 1-12 art. 1514942. doi:10.3389/fphar.2025.1514942NLM
Souza RN de, Visacri MB, Trotta FBA, Ventura D de S, Perroud Junior MW, Moriel P. Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units [Internet]. Frontiers in Pharmacology. 2025 ; 16 1-12 art. 1514942.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.3389/fphar.2025.1514942Vancouver
Souza RN de, Visacri MB, Trotta FBA, Ventura D de S, Perroud Junior MW, Moriel P. Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units [Internet]. Frontiers in Pharmacology. 2025 ; 16 1-12 art. 1514942.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.3389/fphar.2025.1514942
